LTI-03 is formulated as a dry powder inhalation therapy that's designed to help ease fibrosis and symptoms of idiopathic ...

Is vaping cannabis less harmful to your health than smoking it? Many people seem to think so. However, two studies conducted ...

Rein Therapeutics ("Rein") (NASDAQ: RNTX), a biopharmaceutical company advancing a novel pipeline of first-in-class medicines ...

Xenon MRIDURHAM, NC and LONDON, May 15, 2025 (GLOBE NEWSWIRE) -- Polarean Imaging plc (AIM: POLX) (“Polarean” or the “Company”), a commercial-stage medical imaging technology leader in functional ...

The RENEW Phase 2 trial will enroll up to 120 IPF patients with topline data expected in the first half of 2026 In the previously reported Phase 1b study, LTI-03 showed ...

The RENEW Phase 2 trial will enroll up to 120 IPF patients with topline data expected in the first half of 2026 ...

Center for Global Health, The Key Laboratory of Modern Toxicology, Ministry of Education, School of Public Health, Suzhou Institute for Advanced Study of Public Health, Gusu School, Nanjing Medical ...

bGraduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, 34141, Republic of Korea cSamsung Genome Institute, Samsung Medical Center, ...

specifically acting on type 2 alveolar epithelial cells, the progenitors of alveolar cells." The scientific community had overlooked these macrophages because they express a marker previously ...

The study, “Pharmacological expansion of type 2 alveolar epithelial cells promotes regenerative lower airway repair,” was published in PNAS. IPF is a disease of unknown cause that’s marked by scarring ...

In our lab at Swansea University Medical School, we are trying to replicate the layer of cells known as the alveolar epithelium, which lines the deepest part of your lungs where oxygen enters your ...